Home LiteratureArticle Details
PMID: 9418183 Published · ppublish English Journal Article Review

Advances in the understanding of cytokine signal transduction: the role of Jaks and STATs in immunoregulation and the pathogenesis of immunodeficiency.

Journal of clinical immunology ·Vol. 17 ·No. 6 ·1997-11-00 ·Pages 431-47

O'Shea JJ, Notarangelo LD, Johnston JA, Candotti F

Abstract

Cytokines are of great importance in the growth and differentiation of hematopoietic and other cells. Moreover, they are also crucial in immunoregulation and in host defense. Although our understanding of the molecular basis of cytokine action is far from complete, recent advances have substantially improved our knowledge of cytokine-dependent signal transduction. The delineation of the structure of cytokine receptors and the signaling pathways they utilize has provided clues as to how the strikingly specific effects of cytokines are achieved. Additionally, the basis of some of the pleiotropic and redundant effects of cytokines has also become clear. The discovery of the Janus family of protein tyrosine kinases (Jaks) and the STATs (signal transducers and activators of transcription) has also provided key insights into the mechanism by which intracellular signals are transduced. The following paradigm has emerged: cytokines induce dimerization of receptor subunits that are constitutively associated with Jaks. This activates the Jaks, which then phosphorylate the receptors. The phosphorylated receptors are bound by SH2-containing proteins, one class of which is the STATs. Activated STATs, then, translocate to the nucleus to effect gene transcription. Though the Jaks do not explain much in terms of specificity in signaling, the function of the STATs does. The discovery of patients with autosomal recessive severe combined immunodeficiency due to mutations of a particular Jak, Jak3, and the phenotype of knockout mice lacking Jak3 and various STATs demonstrate the specific and critical roles of these molecules in the development and function of the immune system.

MeSH Terms
Adjuvants, Immunologic/physiology Animals Cytokines/metabolism,physiology Humans Immunologic Deficiency Syndromes/etiology Interferon-gamma/physiology Protein-Tyrosine Kinases/physiology Signal Transduction/physiology Trans-Activators/physiology
Chemicals
Adjuvants, Immunologic Cytokines Trans-Activators Interferon-gamma Protein-Tyrosine Kinases
Authors & Affiliations
4 authors, click to expand affiliations / ORCID
O'Shea J J
Lymphocyte Cell Biology Section, National Institute of Arthritis, Musculoskeletal and Skin Diseases, National Institutes of Health, Bethesda, Maryland 20892, USA.
Notarangelo L D
Johnston J A
Candotti F
References (213)
213 references, click to expand
  1. The antiviral state induced by alpha interferon and gamma interferon requires transcriptionally active Stat1 protein.
    J Virol. 1996 Jan;70(1):647-50 PMID: 8523587
  2. Constitutive activation of STAT proteins in primary lymphoid and myeloid leukemia cells and in Epstein-Barr virus (EBV)-related lymphoma cell lines.
    Blood. 1996 Aug 1;88(3):809-16 PMID: 8704235
  3. Stat5a is mandatory for adult mammary gland development and lactogenesis.
    Genes Dev. 1997 Jan 15;11(2):179-86 PMID: 9009201
  4. Jak-STAT signaling induced by the v-abl oncogene.
    Science. 1995 Sep 29;269(5232):1875-7 PMID: 7569929
  5. Impaired IL-13-mediated functions of macrophages in STAT6-deficient mice.
    J Immunol. 1996 Oct 15;157(8):3220-2 PMID: 8871614
  6. Stripe-specific regulation of pair-rule genes by hopscotch, a putative Jak family tyrosine kinase in Drosophila.
    Genes Dev. 1994 Feb 1;8(3):300-12 PMID: 8314084
  7. STATs: signal transducers and activators of transcription.
    Cell. 1996 Feb 9;84(3):331-4 PMID: 8608586
  8. Two novel protein-tyrosine kinases, each with a second phosphotransferase-related catalytic domain, define a new class of protein kinase.
    Mol Cell Biol. 1991 Apr;11(4):2057-65 PMID: 1848670
  9. Immune responses in interleukin-2-deficient mice.
    Science. 1993 Nov 12;262(5136):1059-61 PMID: 8235625
  10. Nuclear integration of JAK/STAT and Ras/AP-1 signaling by CBP and p300.
    Proc Natl Acad Sci U S A. 1997 Feb 18;94(4):1074-9 PMID: 9037008
  11. A JAK1/JAK2 chimera can sustain alpha and gamma interferon responses.
    Mol Cell Biol. 1997 Feb;17 (2):695-706 PMID: 9001223
  12. Interaction of IL-2R beta and gamma c chains with Jak1 and Jak3: implications for XSCID and XCID.
    Science. 1994 Nov 11;266(5187):1042-5 PMID: 7973658
  13. Cytokine receptor signalling.
    Nature. 1995 Oct 19;377(6550):591-4 PMID: 7566171
  14. Phosphorylation and activation of the Jak-3 Janus kinase in response to interleukin-2.
    Nature. 1994 Jul 14;370(6485):151-3 PMID: 8022485
  15. Multiple defects of immune cell function in mice with disrupted interferon-gamma genes.
    Science. 1993 Mar 19;259(5102):1739-42 PMID: 8456300
  16. A transcription factor with SH2 and SH3 domains is directly activated by an interferon alpha-induced cytoplasmic protein tyrosine kinase(s).
    Cell. 1992 Jul 24;70(2):323-35 PMID: 1638633
  17. Interferon-gamma-receptor deficiency in an infant with fatal bacille Calmette-Guérin infection.
    N Engl J Med. 1996 Dec 26;335(26):1956-61 PMID: 8960475
  18. Homodimerization of the human interleukin 4 receptor alpha chain induces Cepsilon germline transcripts in B cells in the absence of the interleukin 2 receptor gamma chain.
    Proc Natl Acad Sci U S A. 1997 May 27;94(11):5866-71 PMID: 9159166
  19. Regulation of JAK3 expression and activation in human B cells and B cell malignancies.
    J Immunol. 1995 Dec 1;155(11):5220-6 PMID: 7594533
  20. Crystal structure of a complex between interferon-gamma and its soluble high-affinity receptor.
    Nature. 1995 Jul 20;376(6537):230-5 PMID: 7617032
  21. JAK2 associates with the erythropoietin receptor and is tyrosine phosphorylated and activated following stimulation with erythropoietin.
    Cell. 1993 Jul 30;74(2):227-36 PMID: 8343951
  22. Targeted disruption of the mouse Stat3 gene leads to early embryonic lethality.
    Proc Natl Acad Sci U S A. 1997 Apr 15;94(8):3801-4 PMID: 9108058
  23. Protein modules and signalling networks.
    Nature. 1995 Feb 16;373(6515):573-80 PMID: 7531822
  24. Functional activation of Jak1 and Jak3 by selective association with IL-2 receptor subunits.
    Science. 1994 Nov 11;266(5187):1045-7 PMID: 7973659
  25. The rapid inactivation of nuclear tyrosine phosphorylated Stat1 depends upon a protein tyrosine phosphatase.
    EMBO J. 1996 Nov 15;15(22):6262-8 PMID: 8947049
  26. Tyrosyl phosphorylation and DNA binding activity of signal transducers and activators of transcription (STAT) proteins in hematopoietic cell lines transformed by Bcr/Abl.
    J Exp Med. 1996 Mar 1;183(3):811-20 PMID: 8642285
  27. Interleukin-10-deficient mice develop chronic enterocolitis.
    Cell. 1993 Oct 22;75(2):263-74 PMID: 8402911
  28. JAK2 associates with the beta c chain of the receptor for granulocyte-macrophage colony-stimulating factor, and its activation requires the membrane-proximal region.
    Mol Cell Biol. 1994 Jul;14(7):4335-41 PMID: 8007942
  29. Functionally distinct isoforms of STAT5 are generated by protein processing.
    Immunity. 1997 Jun;6(6):691-701 PMID: 9208842
  30. Elf-1 and Stat5 bind to a critical element in a new enhancer of the human interleukin-2 receptor alpha gene.
    Mol Cell Biol. 1996 Dec;16(12):6829-40 PMID: 8943338
  31. Interleukin-2 receptor gamma chain: a functional component of the interleukin-4 receptor.
    Science. 1993 Dec 17;262(5141):1880-3 PMID: 8266078
  32. Jak-STAT pathways and transcriptional activation in response to IFNs and other extracellular signaling proteins.
    Science. 1994 Jun 3;264(5164):1415-21 PMID: 8197455
  33. Haemopoietic receptors and helical cytokines.
    Immunol Today. 1990 Oct;11(10):350-4 PMID: 2171545
  34. Missense mutation in exon 7 of the common gamma chain gene causes a moderate form of X-linked combined immunodeficiency.
    J Clin Invest. 1995 Mar;95(3):1169-73 PMID: 7883965
  35. SH2 signaling in a lower eukaryote: a STAT protein that regulates stalk cell differentiation in dictyostelium.
    Cell. 1997 Jun 13;89(6):909-16 PMID: 9200609
  36. Activation of JAK kinases and STAT proteins by interleukin-2 and interferon alpha, but not the T cell antigen receptor, in human T lymphocytes.
    EMBO J. 1994 Dec 1;13(23 ):5605-15 PMID: 7988557
  37. Mutation in the Jak kinase JH2 domain hyperactivates Drosophila and mammalian Jak-Stat pathways.
    Mol Cell Biol. 1997 Mar;17(3):1562-71 PMID: 9032284
  38. The BCL-6 proto-oncogene controls germinal-centre formation and Th2-type inflammation.
    Nat Genet. 1997 Jun;16(2):161-70 PMID: 9171827
  39. IL-15: a pleiotropic cytokine with diverse receptor/signaling pathways whose expression is controlled at multiple levels.
    Immunity. 1996 Apr;4(4):329-36 PMID: 8612127
  40. Regulation of interferon-gamma-activated STAT1 by the ubiquitin-proteasome pathway.
    Science. 1996 Sep 20;273(5282):1717-9 PMID: 8781235
  41. Interleukin-3 signals through multiple isoforms of Stat5.
    EMBO J. 1995 Apr 3;14(7):1402-11 PMID: 7537213
  42. Interaction between the components of the interferon gamma receptor complex.
    J Biol Chem. 1995 Sep 8;270(36):20915-21 PMID: 7673114
  43. Essential role of Stat6 in IL-4 signalling.
    Nature. 1996 Apr 18;380(6575):627-30 PMID: 8602263
  44. The amino terminus of JAK3 is necessary and sufficient for binding to the common gamma chain and confers the ability to transmit interleukin 2-mediated signals.
    Proc Natl Acad Sci U S A. 1997 Jun 24;94(13):6910-5 PMID: 9192665
  45. Cooperative transcriptional activity of Jun and Stat3 beta, a short form of Stat3.
    Proc Natl Acad Sci U S A. 1995 Sep 26;92(20):9097-101 PMID: 7568080
  46. Jak3 is associated with CD40 and is critical for CD40 induction of gene expression in B cells.
    Immunity. 1997 Apr;6(4):379-87 PMID: 9133417
  47. Lymphoid development in mice with a targeted deletion of the interleukin 2 receptor gamma chain.
    Proc Natl Acad Sci U S A. 1995 Jan 17;92(2):377-81 PMID: 7831294
  48. Stat4, a novel gamma interferon activation site-binding protein expressed in early myeloid differentiation.
    Mol Cell Biol. 1994 Jul;14(7):4342-9 PMID: 8007943
  49. Sharing of the IL-2 receptor gamma chain with the functional IL-9 receptor complex.
    Int Immunol. 1995 Jan;7(1):115-20 PMID: 7718508
  50. Cloning and characterization of a specific interleukin (IL)-13 binding protein structurally related to the IL-5 receptor alpha chain.
    J Biol Chem. 1996 Jul 12;271(28):16921-6 PMID: 8663118
  51. The amino-terminal portion of the JAK2 protein kinase is necessary for binding and phosphorylation of the granulocyte-macrophage colony-stimulating factor receptor beta c chain.
    J Biol Chem. 1995 Jun 9;270(23):13814-8 PMID: 7775438
  52. Crucial role of Jak3 in negative selection of self-reactive T cells.
    J Exp Med. 1997 Jan 20;185(2):351-6 PMID: 9016883
  53. Interleukin-2 receptor gamma chain: a functional component of the interleukin-7 receptor.
    Science. 1993 Dec 17;262(5141):1877-80 PMID: 8266077
  54. Lymphocyte responses and cytokines.
    Cell. 1994 Jan 28;76(2):241-51 PMID: 7904900
  55. Functional subdomains of STAT2 required for preassociation with the alpha interferon receptor and for signaling.
    Mol Cell Biol. 1997 Apr;17(4):2048-56 PMID: 9121453
  56. Defective human interleukin 2 receptor gamma chain in an atypical X chromosome-linked severe combined immunodeficiency with peripheral T cells.
    Proc Natl Acad Sci U S A. 1994 Sep 27;91(20):9466-70 PMID: 7937790
  57. gamma-c gene transfer into SCID X1 patients' B-cell lines restores normal high-affinity interleukin-2 receptor expression and function.
    Blood. 1996 Apr 15;87(8):3108-16 PMID: 8605324
  58. Human growth hormone and extracellular domain of its receptor: crystal structure of the complex.
    Science. 1992 Jan 17;255(5042):306-12 PMID: 1549776
  59. Mutations of Jak-3 gene in patients with autosomal severe combined immune deficiency (SCID).
    Nature. 1995 Sep 7;377(6544):65-8 PMID: 7659163
  60. Mutation of Jak3 in a patient with SCID: essential role of Jak3 in lymphoid development.
    Science. 1995 Nov 3;270(5237):797-800 PMID: 7481768
  61. tyk2, prototype of a novel class of non-receptor tyrosine kinase genes.
    Oncogene. 1990 Sep;5(9):1329-36 PMID: 2216457
  62. Interleukin 15 and its receptor.
    Ciba Found Symp. 1995;195:221-9; discussion 229-33 PMID: 8724840
  63. Association and activation of Jak-Tyk kinases by CNTF-LIF-OSM-IL-6 beta receptor components.
    Science. 1994 Jan 7;263(5143):92-5 PMID: 8272873
  64. P210 and P190(BCR/ABL) induce the tyrosine phosphorylation and DNA binding activity of multiple specific STAT family members.
    J Biol Chem. 1996 Dec 6;271(49):31704-10 PMID: 8940193
  65. Generation and analysis of interleukin-4 deficient mice.
    Science. 1991 Nov 1;254(5032):707-10 PMID: 1948049
  66. Cooperative DNA binding and sequence-selective recognition conferred by the STAT amino-terminal domain.
    Science. 1996 Aug 9;273(5276):794-7 PMID: 8670419
  67. Heterodimerization of the IL-2 receptor beta- and gamma-chain cytoplasmic domains is required for signalling.
    Nature. 1994 May 26;369(6478):330-3 PMID: 8183373
  68. Ulcerative colitis-like disease in mice with a disrupted interleukin-2 gene.
    Cell. 1993 Oct 22;75(2):253-61 PMID: 8402910
  69. Impaired IL-12 responses and enhanced development of Th2 cells in Stat4-deficient mice.
    Nature. 1996 Jul 11;382(6587):174-7 PMID: 8700209
  70. Requirement of STAT5b for sexual dimorphism of body growth rates and liver gene expression.
    Proc Natl Acad Sci U S A. 1997 Jul 8;94(14):7239-44 PMID: 9207075
  71. Distinct tumorigenic potential of abl and raf in B cell neoplasia: abl activates the IL-6 signaling pathway.
    Immunity. 1996 Jul;5(1):81-9 PMID: 8758897
  72. Primary immunodeficiency diseases. Report of a WHO Scientific Group.
    Clin Exp Immunol. 1995 Jan;99 Suppl 1:1-24 PMID: 7813117
  73. A protein tyrosine kinase in the interferon alpha/beta signaling pathway.
    Cell. 1992 Jul 24;70(2):313-22 PMID: 1386289
  74. Naturally occurring primary deficiencies of the immune system.
    Annu Rev Immunol. 1997;15:93-124 PMID: 9143683
  75. The JAK-STAT pathway in Drosophila.
    Trends Genet. 1997 Mar;13(3):105-10 PMID: 9066269
  76. Complementation by the protein tyrosine kinase JAK2 of a mutant cell line defective in the interferon-gamma signal transduction pathway.
    Nature. 1993 Nov 11;366(6451):166-70 PMID: 7901766
  77. Constitutively activated Jak-STAT pathway in T cells transformed with HTLV-I.
    Science. 1995 Jul 7;269(5220):79-81 PMID: 7604283
  78. Interleukin-7 receptor alpha is essential for the development of gamma delta + T cells, but not natural killer cells.
    J Exp Med. 1996 Jul 1;184(1):289-93 PMID: 8691145
  79. Comparison of the transactivation domains of Stat5 and Stat6 in lymphoid cells and mammary epithelial cells.
    Mol Cell Biol. 1997 Jul;17(7):3663-78 PMID: 9199300
  80. Naturally occurring dominant negative variants of Stat5.
    Mol Cell Biol. 1996 Nov;16(11):6141-8 PMID: 8887644
  81. Structural and functional basis for JAK3-deficient severe combined immunodeficiency.
    Blood. 1997 Nov 15;90(10 ):3996-4003 PMID: 9354668
  82. Two contact regions between Stat1 and CBP/p300 in interferon gamma signaling.
    Proc Natl Acad Sci U S A. 1996 Dec 24;93(26):15092-6 PMID: 8986769
  83. Interleukin-15 up-regulates interleukin-2 receptor alpha chain but down-regulates its own high-affinity binding sites on human T and B cells.
    Eur J Immunol. 1996 Jun;26(6):1235-9 PMID: 8647198
  84. In vitro correction of JAK3-deficient severe combined immunodeficiency by retroviral-mediated gene transduction.
    J Exp Med. 1996 Jun 1;183(6):2687-92 PMID: 8676091
  85. Requirement of serine phosphorylation for formation of STAT-promoter complexes.
    Science. 1995 Mar 31;267(5206):1990-4 PMID: 7701321
  86. Prevention of T cell anergy by signaling through the gamma c chain of the IL-2 receptor.
    Science. 1994 Nov 11;266(5187):1039-42 PMID: 7973657
  87. The Jak kinases differentially associate with the alpha and beta (accessory factor) chains of the interferon gamma receptor to form a functional receptor unit capable of activating STAT transcription factors.
    J Biol Chem. 1995 Jul 21;270(29):17528-34 PMID: 7615558
  88. Activation of Jak/STAT proteins involved in signal transduction pathway mediated by receptor for interleukin 2 in malignant T lymphocytes derived from cutaneous anaplastic large T-cell lymphoma and Sezary syndrome.
    Proc Natl Acad Sci U S A. 1996 Aug 20;93(17 ):9148-53 PMID: 8799169
  89. The hematopoietin receptor superfamily.
    Cytokine. 1993 Mar;5(2):95-106 PMID: 8392875
  90. Deletion of the carboxyl-terminal transactivation domain of MGF-Stat5 results in sustained DNA binding and a dominant negative phenotype.
    Mol Cell Biol. 1996 Oct;16(10):5691-700 PMID: 8816482
  91. Molecular cloning of rat JAK3, a novel member of the JAK family of protein tyrosine kinases.
    FEBS Lett. 1994 Apr 4;342(2):124-8 PMID: 8143863
  92. Stat3: a STAT family member activated by tyrosine phosphorylation in response to epidermal growth factor and interleukin-6.
    Science. 1994 Apr 1;264(5155):95-8 PMID: 8140422
  93. Differential tyrosine phosphorylation of the IFNAR chain of the type I interferon receptor and of an associated surface protein in response to IFN-alpha and IFN-beta.
    EMBO J. 1994 Dec 15;13(24):5871-7 PMID: 7813427
  94. Mammary gland factor (MGF) is a novel member of the cytokine regulated transcription factor gene family and confers the prolactin response.
    EMBO J. 1994 May 1;13(9):2182-91 PMID: 7514531
  95. Maximal activation of transcription by Stat1 and Stat3 requires both tyrosine and serine phosphorylation.
    Cell. 1995 Jul 28;82(2):241-50 PMID: 7543024
  96. Components of a Stat recognition code: evidence for two layers of molecular selectivity.
    Immunity. 1995 Jun;2(6):689-97 PMID: 7796300
  97. Peripheral expression of Jak3 is required to maintain T lymphocyte function.
    J Exp Med. 1997 Jan 20;185(2):197-206 PMID: 9016869
  98. Cloning of human Stat5B. Reconstitution of interleukin-2-induced Stat5A and Stat5B DNA binding activity in COS-7 cells.
    J Biol Chem. 1996 May 3;271(18):10738-44 PMID: 8631883
  99. Stat recruitment by tyrosine-phosphorylated cytokine receptors: an ordered reversible affinity-driven process.
    Immunity. 1995 Jun;2(6):677-87 PMID: 7796299
  100. Genomic sequence, organization, and chromosomal localization of human JAK3.
    Genomics. 1996 Oct 1;37(1):57-61 PMID: 8921370
  101. Enhancement of antiproliferative activity of gamma interferon by the specific inhibition of tyrosine dephosphorylation of Stat1.
    Mol Cell Biol. 1996 Sep;16(9):4932-41 PMID: 8756652
  102. A JAK-STAT pathway regulates wing vein formation in Drosophila.
    Proc Natl Acad Sci U S A. 1996 Jun 11;93(12):5842-7 PMID: 8650180
  103. The state of the STATs: recent developments in the study of signal transduction to the nucleus.
    Curr Opin Cell Biol. 1997 Apr;9(2):233-9 PMID: 9069254
  104. STATs and cytokine specificity.
    Nat Med. 1996 Sep;2(9):968-9 PMID: 8782447
  105. Identification and cloning of a novel IL-15 binding protein that is structurally related to the alpha chain of the IL-2 receptor.
    EMBO J. 1995 Aug 1;14(15):3654-63 PMID: 7641685
  106. Expression of Janus kinase 3 in human endothelial and other non-lymphoid and non-myeloid cells.
    J Biol Chem. 1996 Jun 14;271(24):13976-80 PMID: 8662778
  107. Identification and purification of human Stat proteins activated in response to interleukin-2.
    Immunity. 1995 Apr;2(4):321-9 PMID: 7719937
  108. Molecular cloning of L-JAK, a Janus family protein-tyrosine kinase expressed in natural killer cells and activated leukocytes.
    Proc Natl Acad Sci U S A. 1994 Jul 5;91(14 ):6374-8 PMID: 8022790
  109. Functional participation of the IL-2 receptor gamma chain in IL-7 receptor complexes.
    Science. 1994 Mar 11;263(5152):1453-4 PMID: 8128231
  110. Interactions between STAT and non-STAT proteins in the interferon-stimulated gene factor 3 transcription complex.
    Mol Cell Biol. 1996 Dec;16(12):6957-64 PMID: 8943351
  111. Activation of a Drosophila Janus kinase (JAK) causes hematopoietic neoplasia and developmental defects.
    EMBO J. 1995 Jun 15;14(12):2857-65 PMID: 7796812
  112. Identification of JAK2 as a growth hormone receptor-associated tyrosine kinase.
    Cell. 1993 Jul 30;74(2):237-44 PMID: 8343952
  113. Inhibition of acute lymphoblastic leukaemia by a Jak-2 inhibitor.
    Nature. 1996 Feb 15;379(6566):645-8 PMID: 8628398
  114. The role of shared receptor motifs and common Stat proteins in the generation of cytokine pleiotropy and redundancy by IL-2, IL-4, IL-7, IL-13, and IL-15.
    Immunity. 1995 Apr;2(4):331-9 PMID: 7719938
  115. Defective lymphoid development in mice lacking Jak3.
    Science. 1995 Nov 3;270(5237):800-2 PMID: 7481769
  116. Utilization of the beta and gamma chains of the IL-2 receptor by the novel cytokine IL-15.
    EMBO J. 1994 Jun 15;13(12):2822-30 PMID: 8026467
  117. Cloning and expression of Stat5 and an additional homologue (Stat5b) involved in prolactin signal transduction in mouse mammary tissue.
    Proc Natl Acad Sci U S A. 1995 Sep 12;92(19):8831-5 PMID: 7568026
  118. The proteins of ISGF-3, the interferon alpha-induced transcriptional activator, define a gene family involved in signal transduction.
    Proc Natl Acad Sci U S A. 1992 Aug 15;89(16):7840-3 PMID: 1502204
  119. Interleukin-2 receptor alpha chain regulates the size and content of the peripheral lymphoid compartment.
    Immunity. 1995 Oct;3(4):521-30 PMID: 7584142
  120. Regulation of JAK3 expression in human monocytes: phosphorylation in response to interleukins 2, 4, and 7.
    J Exp Med. 1995 Apr 1;181(4):1425-31 PMID: 7535338
  121. Cloning and characterization of a mouse IL-12 receptor-beta component.
    J Immunol. 1995 Nov 1;155(9):4286-94 PMID: 7594587
  122. Constitutive activation of STAT5 by the BCR-ABL oncogene in chronic myelogenous leukemia.
    Oncogene. 1996 Jul 18;13(2):247-54 PMID: 8710363
  123. Stat1 depends on transcriptional synergy with Sp1.
    J Biol Chem. 1995 Dec 22;270(51):30264-7 PMID: 8530443
  124. Stat3 and Stat4: members of the family of signal transducers and activators of transcription.
    Proc Natl Acad Sci U S A. 1994 May 24;91(11):4806-10 PMID: 7545930
  125. Receptors for interleukin-13 and interleukin-4 are complex and share a novel component that functions in signal transduction.
    EMBO J. 1993 Jul;12(7):2663-70 PMID: 8101483
  126. Interleukin-4-specific signal transduction events are driven by homotypic interactions of the interleukin-4 receptor alpha subunit.
    EMBO J. 1996 Sep 2;15(17 ):4506-14 PMID: 8887542
  127. IL-4 and IL-13 receptors: are they one and the same?
    Immunol Today. 1996 Mar;17(3):108-10 PMID: 8820266
  128. Cooperation of Stat2 and p300/CBP in signalling induced by interferon-alpha.
    Nature. 1996 Sep 26;383(6598):344-7 PMID: 8848048
  129. Defects in B lymphocyte maturation and T lymphocyte activation in mice lacking Jak3.
    Science. 1995 Nov 3;270(5237):794-7 PMID: 7481767
  130. Sharing of the interleukin-2 (IL-2) receptor gamma chain between receptors for IL-2 and IL-4.
    Science. 1993 Dec 17;262(5141):1874-7 PMID: 8266076
  131. An interleukin-4-induced transcription factor: IL-4 Stat.
    Science. 1994 Sep 16;265(5179):1701-6 PMID: 8085155
  132. Human immune disorder arising from mutation of the alpha chain of the interleukin-2 receptor.
    Proc Natl Acad Sci U S A. 1997 Apr 1;94(7):3168-71 PMID: 9096364
  133. Function of the interleukin-2 (IL-2) receptor gamma-chain in biologic responses of X-linked severe combined immunodeficient B cells to IL-2, IL-4, IL-13, and IL-15.
    Blood. 1995 Jan 1;85(1):38-42 PMID: 7803808
  134. Targeted disruption of the mouse Stat1 gene results in compromised innate immunity to viral disease.
    Cell. 1996 Feb 9;84(3):443-50 PMID: 8608598
  135. Disruption of the murine IL-4 gene blocks Th2 cytokine responses.
    Nature. 1993 Mar 18;362(6417):245-8 PMID: 8384701
  136. A mutation in the interferon-gamma-receptor gene and susceptibility to mycobacterial infection.
    N Engl J Med. 1996 Dec 26;335(26):1941-9 PMID: 8960473
  137. Marelle acts downstream of the Drosophila HOP/JAK kinase and encodes a protein similar to the mammalian STATs.
    Cell. 1996 Feb 9;84(3):411-9 PMID: 8608595
  138. Defective lymphoid development in mice lacking expression of the common cytokine receptor gamma chain.
    Immunity. 1995 Mar;2(3):223-38 PMID: 7697543
  139. Interleukin 12 signaling in T helper type 1 (Th1) cells involves tyrosine phosphorylation of signal transducer and activator of transcription (Stat)3 and Stat4.
    J Exp Med. 1995 May 1;181(5):1755-62 PMID: 7722452
  140. A kinase-deficient splice variant of the human JAK3 is expressed in hematopoietic and epithelial cancer cells.
    J Biol Chem. 1995 Oct 20;270(42):25028-36 PMID: 7559633
  141. cDNA cloning and characterization of the human interleukin 13 receptor alpha chain.
    J Biol Chem. 1996 Nov 15;271(46):29265-70 PMID: 8910586
  142. Regulation of the interleukin (IL)-12R beta 2 subunit expression in developing T helper 1 (Th1) and Th2 cells.
    J Exp Med. 1997 Mar 3;185(5):817-24 PMID: 9120387
  143. Signaling by IL-2 and related cytokines: JAKs, STATs, and relationship to immunodeficiency.
    J Leukoc Biol. 1996 Oct;60(4):441-52 PMID: 8864127
  144. Interleukin-2 receptor gamma chain mutation results in X-linked severe combined immunodeficiency in humans.
    Cell. 1993 Apr 9;73(1):147-57 PMID: 8462096
  145. JAK2, a third member of the JAK family of protein tyrosine kinases.
    Oncogene. 1992 Jul;7(7):1347-53 PMID: 1620548
  146. STAT3 activation by cytokines utilizing gp130 and related transducers involves a secondary modification requiring an H7-sensitive kinase.
    Proc Natl Acad Sci U S A. 1995 Jul 18;92(15):6915-9 PMID: 7624343
  147. The IFN gamma receptor: a paradigm for cytokine receptor signaling.
    Annu Rev Immunol. 1997;15:563-91 PMID: 9143700
  148. Interleukin 12 induces tyrosine phosphorylation and activation of STAT4 in human lymphocytes.
    Proc Natl Acad Sci U S A. 1995 Aug 1;92(16):7307-11 PMID: 7638186
  149. An amino acid substitution in the Drosophila hopTum-l Jak kinase causes leukemia-like hematopoietic defects.
    EMBO J. 1995 Apr 3;14(7):1412-20 PMID: 7729418
  150. Activation and association of Stat3 with Src in v-Src-transformed cell lines.
    Mol Cell Biol. 1996 Apr;16(4):1595-603 PMID: 8657134
  151. Deregulated T cell activation and autoimmunity in mice lacking interleukin-2 receptor beta.
    Science. 1995 Jun 9;268(5216):1472-6 PMID: 7770771
  152. Identification of a Stat gene that functions in Drosophila development.
    Cell. 1996 Feb 9;84(3):421-30 PMID: 8608596
  153. Stat6 is required for mediating responses to IL-4 and for development of Th2 cells.
    Immunity. 1996 Mar;4(3):313-9 PMID: 8624821
  154. Developmental defects of lymphoid cells in Jak3 kinase-deficient mice.
    Immunity. 1995 Dec;3(6):771-82 PMID: 8777722
  155. Immune response in mice that lack the interferon-gamma receptor.
    Science. 1993 Mar 19;259(5102):1742-5 PMID: 8456301
  156. Retroviral-mediated gene correction for X-linked severe combined immunodeficiency.
    Blood. 1996 Apr 15;87(8):3097-102 PMID: 8605322
  157. Cytokines and their receptor complexes.
    FASEB J. 1995 Jan;9(1):50-6 PMID: 7821759
  158. A major role for the protein tyrosine kinase JAK1 in the JAK/STAT signal transduction pathway in response to interleukin-6.
    EMBO J. 1995 Apr 3;14 (7):1421-9 PMID: 7537214
  159. Functional diversity of helper T lymphocytes.
    Nature. 1996 Oct 31;383(6603):787-93 PMID: 8893001
  160. Binding sequence of STAT4: STAT4 complex recognizes the IFN-gamma activation site (GAS)-like sequence (T/A)TTCC(C/G)GGAA(T/A).
    Biochem Biophys Res Commun. 1997 Apr 7;233(1):126-32 PMID: 9144409
  161. Structural organization and chromosomal mapping of JAK3 locus.
    Oncogene. 1996 Nov 7;13(9):2009-14 PMID: 8934548
  162. IL-12-deficient mice are defective in IFN gamma production and type 1 cytokine responses.
    Immunity. 1996 May;4(5):471-81 PMID: 8630732
  163. Mouse interleukin-2 receptor alpha gene expression. Interleukin-1 and interleukin-2 control transcription via distinct cis-acting elements.
    J Biol Chem. 1995 May 5;270(18):10743-53 PMID: 7738013
  164. Carrier detection in X-linked severe combined immunodeficiency based on patterns of X chromosome inactivation.
    J Clin Invest. 1987 May;79(5):1395-400 PMID: 2883199
  165. T-lymphocyte differentiation and proliferation in the absence of the cytoplasmic tail of the common cytokine receptor gamma c chain in a severe combined immune deficiency X1 patient.
    Blood. 1996 Sep 1;88(5):1708-17 PMID: 8781427
  166. The protein tyrosine kinase JAK1 complements defects in interferon-alpha/beta and -gamma signal transduction.
    Nature. 1993 Nov 11;366(6451):129-35 PMID: 8232552
  167. Interleukin-4 signaling in B lymphocytes from patients with X-linked severe combined immunodeficiency.
    J Biol Chem. 1997 Mar 14;272(11):7314-9 PMID: 9054429
  168. Cloning and characterization of a binding subunit of the interleukin 13 receptor that is also a component of the interleukin 4 receptor.
    Proc Natl Acad Sci U S A. 1996 Jan 9;93(1):497-501 PMID: 8552669
  169. The Drosophila Tumorous-lethal hematopoietic oncogene is a dominant mutation in the hopscotch locus.
    Mol Gen Genet. 1993 Apr;238(1-2):33-7 PMID: 8479437
  170. Lack of constitutive activation of Janus kinases and signal transduction and activation of transcription factors in Philadelphia chromosome-positive acute lymphoblastic leukemia.
    Blood. 1996 Jun 1;87(11):4911-2 PMID: 8639867
  171. Lack of IL-4-induced Th2 response and IgE class switching in mice with disrupted Stat6 gene.
    Nature. 1996 Apr 18;380(6575):630-3 PMID: 8602264
  172. Nonrandom X chromosome inactivation in natural killer cells from obligate carriers of X-linked severe combined immunodeficiency.
    J Immunol. 1993 Jan 15;150(2):700-4 PMID: 8093460
  173. Direct binding to and tyrosine phosphorylation of the alpha subunit of the type I interferon receptor by p135tyk2 tyrosine kinase.
    Mol Cell Biol. 1994 Dec;14 (12 ):8133-42 PMID: 7526154
  174. Jak1 kinase is required for cell migrations and anterior specification in zebrafish embryos.
    Proc Natl Acad Sci U S A. 1997 Apr 1;94(7):3082-7 PMID: 9096349
  175. Expression, characterization, and genomic structure of carp JAK1 kinase gene.
    DNA Cell Biol. 1996 Oct;15(10 ):827-44 PMID: 8892755
  176. Activation of STAT4 by IL-12 and IFN-alpha: evidence for the involvement of ligand-induced tyrosine and serine phosphorylation.
    J Immunol. 1996 Dec 1;157(11):4781-9 PMID: 8943379
  177. Structure of the murine Jak2 protein-tyrosine kinase and its role in interleukin 3 signal transduction.
    Proc Natl Acad Sci U S A. 1993 Sep 15;90(18):8429-33 PMID: 8378315
  178. Control of inflammation, cytokine expression, and germinal center formation by BCL-6.
    Science. 1997 Apr 25;276(5312):589-92 PMID: 9110977
  179. Signaling mechanisms through cytokine receptors that share signal transducing receptor components.
    Curr Opin Immunol. 1995 Feb;7(1):17-23 PMID: 7772277
  180. Ligand-induced assembly and activation of the gamma interferon receptor in intact cells.
    Mol Cell Biol. 1996 Jun;16(6):3214-21 PMID: 8649432
  181. Requirement for MAP kinase (ERK2) activity in interferon alpha- and interferon beta-stimulated gene expression through STAT proteins.
    Science. 1995 Sep 22;269(5231):1721-3 PMID: 7569900
  182. The human interferon alpha/beta receptor: characterization and molecular cloning.
    Cell. 1994 May 6;77(3):391-400 PMID: 8181059
  183. Transcriptional responses to polypeptide ligands: the JAK-STAT pathway.
    Annu Rev Biochem. 1995;64:621-51 PMID: 7574495
  184. Impaired survival and proliferation in IL-7 receptor-deficient peripheral T cells.
    J Immunol. 1996 Dec 15;157(12):5315-23 PMID: 8955178
  185. Functional interactions between Stat5 and the glucocorticoid receptor.
    Nature. 1996 Oct 24;383(6602):726-8 PMID: 8878484
  186. Molecular cloning of APRF, a novel IFN-stimulated gene factor 3 p91-related transcription factor involved in the gp130-mediated signaling pathway.
    Cell. 1994 Apr 8;77(1):63-71 PMID: 7512451
  187. Screening for mutations causing X-linked severe combined immunodeficiency in the IL-2R gamma chain gene by single-strand conformation polymorphism analysis.
    Hum Genet. 1995 Oct;96(4):427-32 PMID: 7557965
  188. An IL-2 response element in the human IL-2 receptor alpha chain promoter is a composite element that binds Stat5, Elf-1, HMG-I(Y) and a GATA family protein.
    EMBO J. 1996 Oct 15;15(20):5627-35 PMID: 8896456
  189. Targeted disruption of the Stat1 gene in mice reveals unexpected physiologic specificity in the JAK-STAT signaling pathway.
    Cell. 1996 Feb 9;84(3):431-42 PMID: 8608597
  190. Signaling through the hematopoietic cytokine receptors.
    Annu Rev Immunol. 1995;13:369-98 PMID: 7612228
  191. Two mutational hotspots in the interleukin-2 receptor gamma chain gene causing human X-linked severe combined immunodeficiency.
    Am J Hum Genet. 1995 Sep;57(3):564-71 PMID: 7668284
  192. Requirement for Stat4 in interleukin-12-mediated responses of natural killer and T cells.
    Nature. 1996 Jul 11;382(6587):171-4 PMID: 8700208
  193. Involvement of the Jak-3 Janus kinase in signalling by interleukins 2 and 4 in lymphoid and myeloid cells.
    Nature. 1994 Jul 14;370(6485):153-7 PMID: 8022486
  194. Interleukin-3, granulocyte-macrophage colony stimulating factor and interleukin-5 transduce signals through two STAT5 homologs.
    EMBO J. 1995 Mar 15;14(6):1166-75 PMID: 7720707
  195. An activating mutation in the murine erythropoietin receptor induces erythroleukemia in mice: a cytokine receptor superfamily oncogene.
    Cell. 1991 Dec 20;67(6):1089-102 PMID: 1662116
  196. Homodimerization of interleukin-4 receptor alpha chain can induce intracellular signaling.
    J Biol Chem. 1996 Sep 27;271(39):23634-7 PMID: 8798580
  197. Murine JAK3 is preferentially expressed in hematopoietic tissues and lymphocyte precursor cells.
    Blood. 1996 Apr 15;87(8):3151-60 PMID: 8605329
  198. Correction of interleukin-2 receptor function in X-SCID lymphoblastoid cells by retrovirally mediated transfer of the gamma-c gene.
    Blood. 1996 Apr 15;87(8):3103-7 PMID: 8605323
  199. Human severe combined immunodeficiency: genetic, phenotypic, and functional diversity in one hundred eight infants.
    J Pediatr. 1997 Mar;130(3):378-87 PMID: 9063412
  200. Enhanced DNA-binding activity of a Stat3-related protein in cells transformed by the Src oncoprotein.
    Science. 1995 Jul 7;269(5220):81-3 PMID: 7541555
  201. The molecular basis of X-linked severe combined immunodeficiency: defective cytokine receptor signaling.
    Annu Rev Med. 1996;47:229-39 PMID: 8712778
  202. STAT-related transcription factors are constitutively activated in peripheral blood cells from acute leukemia patients.
    Blood. 1996 Mar 1;87(5):1692-7 PMID: 8634413
  203. The common cytokine receptor gamma chain plays an essential role in regulating lymphoid homeostasis.
    J Exp Med. 1997 Jan 20;185(2):189-95 PMID: 9016868
  204. Identification of a novel receptor/signal transduction pathway for IL-15/T in mast cells.
    EMBO J. 1996 Sep 16;15(18):4928-39 PMID: 8890166
  205. Signaling via IL-2 and IL-4 in JAK3-deficient severe combined immunodeficiency lymphocytes: JAK3-dependent and independent pathways.
    Immunity. 1996 Dec;5(6):605-15 PMID: 8986719
  206. Induction of sequence-specific DNA-binding factors by erythropoietin and the spleen focus-forming virus.
    Blood. 1995 Mar 15;85(6):1454-62 PMID: 7888668
  207. IL2RGbase: a database of gamma c-chain defects causing human X-SCID.
    Immunol Today. 1996 Nov;17(11):507-11 PMID: 8961626
  208. JAK3: a novel JAK kinase associated with terminal differentiation of hematopoietic cells.
    Oncogene. 1994 Aug;9(8):2415-23 PMID: 7518579
  209. Regions of the JAK2 tyrosine kinase required for coupling to the growth hormone receptor.
    J Biol Chem. 1995 Jun 16;270(24):14776-85 PMID: 7540178
  210. Distribution of the mammalian Stat gene family in mouse chromosomes.
    Genomics. 1995 Sep 1;29(1):225-8 PMID: 8530075
  211. Cytoplasmic domains of the interleukin-2 receptor beta and gamma chains mediate the signal for T-cell proliferation.
    Nature. 1994 May 26;369(6478):333-6 PMID: 7514277
  212. Lymphopenia in interleukin (IL)-7 gene-deleted mice identifies IL-7 as a nonredundant cytokine.
    J Exp Med. 1995 Apr 1;181(4):1519-26 PMID: 7699333
  213. Selective expression of an interleukin-12 receptor component by human T helper 1 cells.
    J Exp Med. 1997 Mar 3;185(5):825-31 PMID: 9120388
Article Info
Journal
Journal of clinical immunology
Abbr.
J Clin Immunol
ISSN
0271-9142
Published
1997-11-00
Pages
431-47
Language
English
Region
Netherlands
NLM ID
8102137
Subset
IM
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: [email protected]